RhoVac reports first patient enrolled in UK prostate cancer trial
RhoVac AB (Spotlight Sweden:RHOVAC) reported on Thursday that the first patient has been enrolled in its clinical phase IIb study in the UK. RhoVac-002 is a randomised, placebo controlled and double-blind trial designed to evaluate whether treatment with …